Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2018 | 2 |
2021 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Noncoding translation mitigation.
Nature. 2023 May;617(7960):395-402. doi: 10.1038/s41586-023-05946-4. Epub 2023 Apr 12.
Nature. 2023.
PMID: 37046090
Free PMC article.
Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases.
Myeku N, Duff KE.
Myeku N, et al.
Trends Mol Med. 2018 Jan;24(1):18-29. doi: 10.1016/j.molmed.2017.11.006. Epub 2017 Dec 9.
Trends Mol Med. 2018.
PMID: 29233753
Free PMC article.
Review.
Item in Clipboard
PAC1 receptor-mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain.
Schaler AW, Runyan AM, Clelland CL, Sydney EJ, Fowler SL, Figueroa HY, Shioda S, Santa-Maria I, Duff KE, Myeku N.
Schaler AW, et al.
Sci Transl Med. 2021 May 26;13(595):eaba7394. doi: 10.1126/scitranslmed.aba7394.
Sci Transl Med. 2021.
PMID: 34039738
Free PMC article.
Item in Clipboard
Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome-mediated proteolysis and attenuates tauopathy and cognitive decline.
Schaler AW, Myeku N.
Schaler AW, et al.
Transl Res. 2018 Mar;193:31-41. doi: 10.1016/j.trsl.2017.11.004. Epub 2017 Nov 23.
Transl Res. 2018.
PMID: 29232559
Free PMC article.
Item in Clipboard
5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy.
Jiang S, Sydney EJ, Runyan AM, Serpe R, Figueroa HY, Yang M, Myeku N.
Jiang S, et al.
bioRxiv [Preprint]. 2023 Feb 4:2023.02.03.526871. doi: 10.1101/2023.02.03.526871.
bioRxiv. 2023.
PMID: 36778352
Free PMC article.
Updated.
Preprint.
Item in Clipboard
5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy.
Jiang S, Sydney EJ, Runyan AM, Serpe R, Srikanth M, Figueroa HY, Yang M, Myeku N.
Jiang S, et al.
Front Cell Neurosci. 2024 Apr 4;18:1338502. doi: 10.3389/fncel.2024.1338502. eCollection 2024.
Front Cell Neurosci. 2024.
PMID: 38638303
Free PMC article.
Item in Clipboard
Cite
Cite